Search for: "H. LUNDBECK A/S"
Results 21 - 40
of 55
Sorted by Relevance
|
Sort by Date
6 Sep 2007, 12:33 pm
No. 34,712 in favor of Forest Laboratories and H. [read post]
7 Jan 2024, 9:59 pm
Lundbeck A/S v. [read post]
7 Jul 2020, 6:04 am
Lundbeck A/S v. [read post]
15 Apr 2011, 4:09 am
Court of Appeal (Civil Division) Cardinal Vaughan Memorial School, R (on the application of) v The Archbishop of Westminster & Anor [2011] EWCA Civ 433 (14 April 2011) H and L v A City Council [2011] EWCA Civ 403 (14 April 2011) Marcroft v Heartland (Midlands) Ltd [2011] EWCA Civ 438 (14 April 2011) Desai v National Car Parks Services (NCP) [2011] EWCA Civ 402 (14 April 2011) Court of Appeal (Criminal Division) Deeney, R. v [2011] EWCA Crim 893 (14 April 2011) R & Anor, R. v [2011]… [read post]
28 May 2016, 7:13 pm
Furthermore, it has been held that ‘everything that is within the scope of a claim must be useful, otherwise the claim will fail for inutility’ (H Lundbeck A/S v Alphapharm Pty Ltd [2009] FCAFC 70 at [81]).One aspect of the utility requirement that has perhaps been less consistently addressed is whether, if a patent applicant makes multiple promises for an invention, it is necessary that all of those promises be met by every claim. [read post]
6 May 2009, 3:29 am
See now Alphapharm Pty Ltd v H Lundbeck A/S [2008] FCA 559 at [643]ff. [read post]
11 Dec 2023, 7:43 am
Lundbeck A/S v. [read post]
17 Jun 2009, 3:02 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
17 Jun 2009, 3:02 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
22 Jul 2010, 8:35 am
Pharma IQ’s BioPatent Design offers you the perfect gathering to find your solutions. [read post]
2 Apr 2009, 1:40 am
H. [read post]
13 Sep 2007, 1:13 am
H. [read post]
9 Jun 2015, 1:06 pm
“More than one-fifth of all health-related disability is caused by mental ill health, studies suggest,” wrote Allan H. [read post]
27 Feb 2009, 5:00 am
USA, Inc (Orange Book Blog) (FDA Law Blog) (Patent Baristas) (Law360) (Patent Docs) (Patent Prospector) (Patently-O) (GenericsWeb) (Hal Wegner) Cipramil (Citalopram) – UK: House of Lords upholds second-generation patent that had been invalidated at first instance for insufficiency: Generics (UK) Limited and others v H Lundbeck A/S (Managing Intellectual Property)(IPKat) US: Congressman Waxman tells GPhA meeting that Hatch-Waxman model will work for follow-on… [read post]
14 Jul 2010, 6:47 pm
Glaxo tries a ‘Linux’ (Spicy IP) TB Alliance and DNDi team up to fight neglected diseases (IP Watch) Australia: Pharmaceuticals extensions and international inequities: H Lundbeck A/S v Alphapharm Pty Ltd, Ortho-McNeil Pharmaceutical, Inc v Lupin Pharmaceuticals, Inc (Patentology) Australia: The ‘morality’ of gene patents (Patentology) Belgium: Antwerp commercial court finds Belgian counterpart of EU patent covering process for producing L-Lysine by… [read post]
1 Jul 2009, 7:14 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
22 Jul 2009, 6:05 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
7 Jan 2020, 7:26 am
In addition to the often cited passage of Kitchin J in Generics v H Lundbeck ([2007] EWHC 1040) on the factors for obviousness, Lord Hodge added &ldq [read post]
21 Jul 2014, 10:32 am
For example, as was stated in Generics (UK) Limited and others v H Lundbeck A/S [2009] UKHL 12: “National courts may reach different conclusions as to the evaluation of the evidence in the light of the relevant principles, but the principles themselves should be the same, stemming as they do from the EPC. [read post]
4 Mar 2009, 11:00 pm
(Spicy IP) Kenya enacts Biosafety Act 2/2009 regulating activities in GMOs, establishing National Biosafety Authority (Afro-IP) US: BIO meets the press: economic health of the biotech industry; follow-on biologics; patent reform (Patent Docs) (Patent Docs) (Intellectual Property Watch) US: Obama touts generic biologics to lower drug costs (Law360) US: Genentech announces victory in Cabilly re-examination (Patent Docs) US: Federal judge rejects Scruggs family’s bid to reconsider… [read post]
